Two years before the release of Nosferatu, Robert Eggers directed the epic action drama film The Northman. After an underwhelming theatrical run, the film is now enjoying newfound global success on ...

Vinland Saga’s story has ended in the pages of its manga with its latest chapter, but this doesn’t mean that Thorfinn’s story is entirely finished. With a third season yet to be confirmed for the ...

Disappointing tolerability results accompanied impressive body weight loss data. It's a setback, but Viking Therapeutics still has strategic options. The trial may have contained a tough sample group.

A24's new dub of the Chinese animated film features Michelle Yeoh in the telling of a high fantasy animated adventure. “Ne Zha 2” isn’t the first Chinese film to challenge Hollywood productions in ...

This week's free games thrust you into the shoes of a mysterious proprietor at a local plant store and an employee at a frog refuge. What could be better than that? Not much. Aimee Hart has been a ...

The safety and tolerability data were at odds with an earlier phase 1 trial, and not as good as a comparable drug trial result from Eli Lilly. Viking may decide to take VK2735 (oral form) through ...

Aug 19 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a mid-stage trial, missing Wall ...

Viking stock dropped after Phase 2 obesity pill data showed higher discontinuations. William Blair kept an Outperform rating, calling the sell-off excessive. Get Discounted Real-Time Trade Alerts For ...

(Reuters) - Viking Therapeutics said on Tuesday its experimental weight-loss pill helped people with obesity lose up to 12.2% of their body weight over 13 weeks in a keenly watched study. Yet, shares ...

Led by strength in its Ocean voyages, Viking Holdings (NYSE:VIK) realized a 19% increase in revenue during the second quarter, driving the company’s adjusted profits up 24% per share. Shares are under ...

Notes: 1) Safety population, includes all randomized subjects who received at least one dose of study drug. 2) Patients treated with VK2735 were titrated to final doses as indicated: 15 mg cohort = 15 ...

(RTTNews) - Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, Tuesday announced positive top-line results from its Phase 2 VENTURE study of the oral tablet formulation of ...